false --04-30 2025 Q3 0001854183 0001854183 2024-05-01 2025-01-31 0001854183 2025-01-31 0001854183 2024-04-30 0001854183 2024-11-01 2025-01-31 0001854183 2023-11-01 2024-01-31 0001854183 2023-05-01 2024-01-31 0001854183 us-gaap:CommonStockMember 2023-04-30 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001854183 us-gaap:RetainedEarningsMember 2023-04-30 0001854183 2023-04-30 0001854183 us-gaap:CommonStockMember 2023-07-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001854183 us-gaap:RetainedEarningsMember 2023-07-31 0001854183 2023-07-31 0001854183 us-gaap:CommonStockMember 2023-10-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001854183 us-gaap:RetainedEarningsMember 2023-10-31 0001854183 2023-10-31 0001854183 us-gaap:CommonStockMember 2024-04-30 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0001854183 us-gaap:RetainedEarningsMember 2024-04-30 0001854183 us-gaap:CommonStockMember 2024-07-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-07-31 0001854183 us-gaap:RetainedEarningsMember 2024-07-31 0001854183 2024-07-31 0001854183 us-gaap:CommonStockMember 2024-10-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0001854183 us-gaap:RetainedEarningsMember 2024-10-31 0001854183 2024-10-31 0001854183 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001854183 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001854183 2023-05-01 2023-07-31 0001854183 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001854183 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001854183 2023-08-01 2023-10-31 0001854183 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0001854183 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001854183 us-gaap:CommonStockMember 2024-05-01 2024-07-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-05-01 2024-07-31 0001854183 us-gaap:RetainedEarningsMember 2024-05-01 2024-07-31 0001854183 2024-05-01 2024-07-31 0001854183 us-gaap:CommonStockMember 2024-08-01 2024-10-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-08-01 2024-10-31 0001854183 us-gaap:RetainedEarningsMember 2024-08-01 2024-10-31 0001854183 2024-08-01 2024-10-31 0001854183 us-gaap:CommonStockMember 2024-11-01 2025-01-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-11-01 2025-01-31 0001854183 us-gaap:RetainedEarningsMember 2024-11-01 2025-01-31 0001854183 us-gaap:CommonStockMember 2024-01-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001854183 us-gaap:RetainedEarningsMember 2024-01-31 0001854183 2024-01-31 0001854183 us-gaap:CommonStockMember 2025-01-31 0001854183 us-gaap:AdditionalPaidInCapitalMember 2025-01-31 0001854183 us-gaap:RetainedEarningsMember 2025-01-31 0001854183 srt:DirectorMember 2022-04-14 2022-04-15 0001854183 ORIB:ThreeShareholdersMember 2023-07-01 2023-07-31 0001854183 ORIB:TwentyNineShareholdersMember 2022-09-01 2023-01-31 0001854183 ORIB:FiveShareholdersMember 2022-11-01 2023-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

Mark One

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File No. 333-257326

ORION BLISS CORP.

(Exact name of registrant as specified in its charter)

Nevada

2840

EIN 98-1591444

(State or other jurisdiction of incorporation or Organization)

(Primary Standard Industrial

Classification Code Number)

(IRS Employer

Identification Number)

Ashdod

Kalonite 9-57

Israel

7724233

Tel +1 307 298 0969

Email: orionbliss123456@gmail.com

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by checkmark whether the issuer has filed all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the most practicable date:

Class	Outstanding as of January 31, 2025
Common Stock: $0.0001	3,038,000

TABLE OF CONTENTS

PART 1.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Balance Sheets as of January 31, 2025 (unaudited) and April 30, 2024 (audited)	3
	Statement of Operations for the three and nine months ended January 31, 2025 and 2024 (Unaudited)	4
	Statement of Stockholders’ Equity (Deficit) from Inception ended January 31, 2025 (Unaudited)	5
	Statement of Cash Flows for the nine months ended January 31, 2025 and 2024 (Unaudited)	6
	Notes to the Financial Statements (Unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14
Item 4.	Controls and Procedures	14

PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	15
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3.	Defaults Upon Senior Securities	15
Item 4.	Mine safety disclosures	15
Item 5.	Other Information	15
Item 6.	Exhibits	15
	Signatures	16

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL INFORMATION

ORION BLISS CORP.

BALANCE SHEETS

	January 31, 2025			April 30, 2024
	(Unaudited)			(Audited)
ASSETS
Current Assets
Escrow Account	$	11,561		$	1,190
Mobile Application		45,500			–
Accumulated Depreciation		(2,275	)		–
Total Current Assets		54,786			1,190

Website Development, net		134			134
Total Assets	$	54,920		$	1,324

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current Liabilities
Interest Payable	$	1,138		$	–
Accounts payable - Related party		46,000			37,000
Director loan		66,929			53,517
Note Payable		45,500			–
Total Current Liabilities		159,567			90,517

Stockholders’ Deficit
Common stock, par value $0.0001; 75,000,000 shares authorized, 3,038,000 shares issued and outstanding respectively;		304			304
Additional paid-in capital		20,656			20,656
Accumulated deficit		(125,607	)		(110,153	)
Total Stockholders’ Deficit		(104,647	)		(89,193	)

Total Liabilities and Stockholders’ Deficit	$	54,920		$	1,324

The accompanying notes are an integral part of these condensed financial statements

ORION BLISS CORP.

STATEMENT OF OPERATIONS

(Unaudited)

	Three Months Ended January 31, 2025			Three Months Ended January 31, 2024			Nine Months Ended January 31, 2025			Nine Months Ended January 31, 2024

REVENUE (Consulting services)	$	8,765		$	–		$	14,765		$	–

General and Administrative Expenses		9,808			7,263			30,219			44,889

NET INCOME (LOSS) FROM OPERATION		(1,043	)		(7,263	)		(15,454	)		(44,889	)

PROVISION FOR TAXES		–			–			–			–

NET INCOME (LOSS)	$	(1,043	)	$	(7,263	)	$	(15,454	)	$	(44,889	)

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED		3,038,000			3,038,000			3,038,000			3,038,000

The accompanying notes are an integral part of these condensed financial statements

ORION BLISS CORP.

STATEMENTS OF STOCKHOLDER EQUITY

(Unaudited)


	Common Stock				Additional Paid-in		Deficit Accumulated during the Development			Total Stockholders’
	Shares		Amount		Capital		Stage			Equity

Balance, April 30, 2023		3,038,000	$	304	$	20,656	$	(57,797	)	$	(36,837	)

Net loss for the quarter ending July 31, 2023		–		–		–		(33,623	)		(33,623	)

Balance, July 31, 2023		3,038,000	$	304	$	20,656	$	(91,420	)	$	(70,460	)

Net loss for the quarter ending October 31, 2023		–		–		–		(4,003	)		(4,003	)

Balance, October 31, 2023		3,038,000	$	304	$	20,656	$	(95,423	)	$	(74,463	)

Net loss for the quarter ending January 31, 2024		–		–		–		(7,263	)		(7,263	)

Balance, January 31, 2024		3,038,000	$	304	$	20,656	$	(102,686	)	$	(81,726	)



Balance, April 30, 2024		3,038,000	$	304	$	20,656	$	(110,153	)	$	(89,193	)

Net loss for the quarter ending July 31, 2024		–		–		–		(13,505	)		(13,505	)

Balance, July 31, 2024		3,038,000	$	304	$	20,656	$	(123,658	)	$	(102,698	)

Net loss for the quarter ending October 31, 2024		–		–		–		(906	)		(906	)

Balance October 31, 2024		3,038,000	$	304	$	20,656	$	(124,564	)	$	(103,604	)

Net loss for the quarter ending January 31, 2025		–		–		–		(1,043	)		(1,043	)

Balance January 31, 2025		3,038,000	$	304	$	20,656	$	(125,607	)	$	(104,647	)

The accompanying notes are an integral part of these condensed financial statements

ORION BLISS CORP.

STATEMENT OF CASH FLOWS

(Unaudited)

	Nine Months Ended January 31, 2025			Nine Months Ended January 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) for the period	$	(15,454	)	$	(44,889	)
Adjustments to reconcile net loss to net cash used in operating activities:
Note Payable		45,500			–
Accrued Accumulated amortization		2,275			–
Changes in assets and liabilities:
CASH FLOWS USED IN OPERATING ACTIVITIES		32,321			(44,889	)

CASH FLOWS FROM INVESTING ACTIVITIES
Mobile application		(45,500	)		–
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES		(45,500	)		–

CASH FLOWS FROM FINANCING ACTIVITIES
Interest payable		1,138			–
Accounts Payable - Related Party		9,000			9,000
Related Party loans		13,412			28,248
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		23,550			37,248

Net Cash Increase (Decrease) for Period		10,371			(7,641	)
Cash at the beginning of Period		1,190			7,781
Cash at end of Period	$	11,561		$	140

SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	$	–		$	–
Income taxes paid	$	–		$	–

The accompanying notes are an integral part of these condensed financial statements

ORION BLISS CORP.

Notes to the Financial Statements

January 31, 2025 and 2024

(Unaudited)

Note 1 – ORGANIZATION AND NATURE OF BUSINESS

Orion Bliss Corp. (referred as the “Company”, “we”, “our”) was Incorporated in the State of Nevada and established on March 23, 2021. We are a development-stage company formed to commence operations related to selling Milk_shake hairline products. In addition to offering a wide range of hair care products, our company now provides specialized beauty consulting services and beauty care training programs. Our consulting service offers personalized advice, guiding clients to select the best hair care products and routines suited to their unique hair types and goals. We also conduct training sessions for individuals and professionals, covering everything from hair health basics to advanced styling and treatment techniques. The Company is operating in hair and beauty care business through https://orion-bliss.com/ (the “Website”) and https://play.google.com/store/apps/details?id=com.orion.bliss (the “Mobile Application”) principally in Israel.

Our office is located at Kalonite 9-57, Ashdod, Israel, zip code 7724233.

Note 2 – GOING CONCERN

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern. The Company has an accumulated deficit of $125,607 as of January 31, 2025 and $110,153 as of April 30, 2024. The Company has Promissory Notes on a balance sheet of $45,500 at January 31, 2025. The Company currently has losses and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three -months ended January 31, 2025, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2024. These unaudited condensed financial statements should be read in conjunction with the April 30, 2024, financial statements and notes thereto.

Revenue

In accordance with ASC 606, revenue is measured based on a consideration specified with a customer and recognized when we satisfy the performance obligation specified with a customer.

During the three month and nine month periods ended January 31, 2025, we have generated $8,765 and $14,765 revenue, respectively.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Deferred Offering Costs

Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, Other Assets and Deferred Costs, allows specific, incremental costs directly related to securities offerings to be deferred and charged against the gross proceed of the offering. The Company defers applicable syndication expenses based on these criteria. The Company will write off all deferred offering costs if a securities offering is aborted.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.

Mobile Application and Website development - amortization

The Company is using straight - line amortization for our mobile application and website since they are fully operational as of October 31, 2024.

Mobile Application and Website – $45,500.

Term of amortization – 60 months (5 years).

Since October 31, 2024 to January 31, 2025 the company’s accumulated amortization was $2,275.

Interest Payable Note

The Company holds Promissory note payable of $45,500, as per contract the company has to pay interest of 10% annually. As of January 31, 2025 the Company’s Interest payable is $1,138.

Fair Value of Financial Instruments

Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value.

For the three levels are defined as follows:

Level 1:	defined as observable inputs such as quoted prices in active markets;
Level 2:	defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3:	defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at January 31, 2025.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

Long-Lived Assets – Intangible Assets

We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of January 31, 2025, there were no potentially dilutive debt or equity instruments issued or outstanding.

Recent Accounting Pronouncements

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

Risks and Uncertainties

In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally.

The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations.

Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

Financial Statement Reclassification

Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications.

Note 4 – COMMON STOCK

The Company has 75,000,000, $0.0001 par value shares of common stock authorized.

On April 15, 2022 the Company issued 2,000,000 shares of common stock to a director for services rendered estimated to be $200 at $0.0001 per share.

In July, 2023, the Company issued 65,500 shares of common stock to 3 shareholders in consideration of $1,310.

In September and January 2023, the Company issued 822,500 shares of common stock to 29 shareholders at $0.02 per share in consideration of $16,450.

In November and December 2022 followed by January 2023, the Company issued 150,000 shares of common stock to 5 shareholders at $0.02 per share in consideration of $3,000.

There were 3,038,000 shares of common stock issued and outstanding as of January 31, 2025.

Voting Common Stock

All shares of common stock have voting rights and are identical. All holders of shares of voting common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder.

Non-voting Common Stock

All of the other terms of the Non-Voting Common Stock shall be identical to the Voting Common Stock, except for the right of first refusal that attaches to the Non-Voting Common Stock, as explained in the Company’s Bylaws.

Note 5 – INCOME TAXES

On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018.

The reconciliation of income tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows:

	January 31, 2025

Tax benefit (expenses) at U.S. statutory rate	$	(219	)
Change in valuation allowance		219
Tax benefit (expenses), net	$	–

The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows:

Schedule of deferred taxes	January 31, 2025

Net operating loss	$	(26,377	)
Valuation allowance		26,377
Deferred tax assets, net	$	–

The Company has accumulated approximately $125,607 of net operating losses (“NOL”) carried forward to offset future taxable income up to 20 years, if any, in future years which begin to expire in year 2038. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

Note 6 – COMMITMENTS AND CONTINGENCIES

Our sole officer and director, Alexandra Solomovskaya, has agreed to provide her own premise under office needs. She will not take any fee for these premises it is for free use.

Note 7 – SUBSEQUENT EVENTS

In accordance with ASC 855-10 the Company has analyzed its operations subsequent to January 31, 2025 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements” made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the “Act”) and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Employees and Employment Agreements

At present, we have no employees other than our officer and director. We presently do not have pension, health, annuity, insurance, stock options, profit sharing or similar benefit plans; however, we may adopt such plans in the future. There are presently no personal benefits available to any officers, directors or employees.

Results of Operation

Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Three and Nine Months Ended January 31, 2025 and 2024:

During the three and nine months ended January 31, 2025 the Company has generated $8,765 and $14,765 revenue.

Our net loss for the three and nine months ended January 31, 2025 was $1,043 and $15,454. Operating expenses consist of mainly professional fees.

During the three and nine months ended January 31, 2024 the Company has not generated any revenue.

Our net loss for the three and nine months ended January 31, 2024 was $7,263 and $44,889. Operating expenses consist of mainly professional fees.

Liquidity and Capital Resources

As of January 31, 2025, our total assets were $54,920 consisting of website development, net of $134, mobile application $45,500, cash $11,561 from issuance of common stock and accumulated amortization $2,275. As of January 31, 2025, our current liabilities were $159,567 consisting of accounts payable-related party advances of $46,000, director loan of $66,929, note payable of $45,500 and interest payable $1,138.

Cash Flows from Operating Activities

We have generated positive cash flows from operating activities. For the nine months ended January 31, 2025, net cash flows used in operating activities were $32,321.

We have not generated positive cash flows from operating activities. For the nine months ended January 31, 2024, net cash flows used in operating activities were $44,889.

Cash Flows from Investing Activities

We have not generated positive cash flows from investing activities. For the nine months ended January 31, 2025 we used $45,500 in investing activities.

Cash Flows from Financing Activities

We have generated positive cash flows from financing activities in the amount $23,550 during the nine months ended January 31, 2025. During the nine months ended January 31, 2024 we generated positive cash flows from financing activities of $37,248.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.

Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

Off-Balance Sheet Arrangements

As of the date of this Quarterly Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Going Concern

The financial statements have been prepared "assuming that we will continue as a going concern", which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

No report required.

ITEM 4. CONTROLS AND PROCEDURES

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2025. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Such officer also confirmed that there was no change in our internal control over financial reporting during the three-month period ended January 31, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

No report required.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

No report required.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

During the nine months ended January 31, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

The following exhibits are included as part of this report by reference:

31.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1		Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in Ashdod, Kalonite 9-57 Israel 7724233.

	ORION BLISS CORP.


	By:	/s/ Alexandra Solomovskaya
		President, Treasurer and Secretary
		(Principal Executive, Financial and Accounting Officer)

In accordance with the requirements of the Securities Act of 1933, this registration statement was signed by the following persons in the capacities and on the dates stated.

Signature	Title	Date

/s/ Alexandra Solomovskaya
Alexandra Solomovskaya	President, Treasurer, Secretary and Director (Principal Executive, Financial and Accounting Officer)	February 25, 2025

Orion Bliss Corp. 10-Q